Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Gynecologic 3Tumor-Agnostic 2Genitourinary 2Classical hematology 2CNS 2Breast 2Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 2Thromboembolism 1Postoperative Hemorrhage 1Blood Loss, Surgical 1Advanced Ovarian Cancer 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Tranexamic Acid × Gynecologic × Clear all
NCT06879353 2025-03-19

Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

Sheikh Zayed Medical College

Phase NA Completed
372 enrolled
Gynecologic

Ovarian Neoplasms

NCT04360629 2022-06-01

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Fudan University

Phase NA Completed
151 enrolled
Gynecologic

Advanced Ovarian Cancer

NCT00740116 2022-03-15

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

University Hospital, Linkoeping

Phase 4 Completed
100 enrolled 11 charts
Gynecologic

Ovarian Neoplasms, Thromboembolism, Blood Loss, Surgical, Postoperative Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡